Skip to content
Institutional Investor Series A Series B growth early-stage Est. 2015

dRx Capital

Tech and Life Sciences focused early-stage VC firm investing in the US

📍 Basel, Switzerland

About This Fund

dRx Capital is an early-stage venture capital firm that makes invests in the US. The firm focuses on Tech companies including sectors such as Mobile Technology and IT. Also, it invests in Life Sciences start-ups engaged in sectors like Pharmaceutical. Top investments include Cala Health, Science 37, Omada Health. The firm is a joint investment company launched by Novartis and Qualcomm.

Investment Focus

Sectors
digital health healthtech biotech AI/ML healthcare big data healthcare pharma services IT R&D optimization patient care pharma supply chain commercialization tech
Stages
Series A Series B growth early-stage
Check Size $4M-$30M
Geography
USA UK Switzerland

What They Look For

digital health/pharma IT focus; Series A+; primarily US, Switzerland, UK; exceptional teams leveraging data/digital tech for healthcare transformation; backed by Novartis/Qualcomm networks

Preparing to pitch dRx Capital?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →